Session includes LIVE Q&A
Your feedback is valued - please complete the session evaluation: https://www.surveymonkey.co.uk/r/BN6BDKH
Advances in Migraine Prevention: What's New?
Case Discussion: how can we improve the lives of patients with difficult-to-treat migraines?;
Targeted Therapies: targeted evidence - anti-CGRP monoclonal antibodies in difficult-to-treat migraine;
Neuropeptide tagets in migraine pathophysiology - what does the latest research tell us and what do we still need to learn?